NCT05022667 2025-08-08
Assessing Benefits of Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Total Thyroidectomy
University of Michigan
Phase NA Completed
Clinical Trials
15 trialsNCT05579782 2025-07-31
Assessing Benefits of NIRAF Detection for Identifying Parathyroid Glands During Total Thyroidectomy
Medical College of Wisconsin
Phase NA Completed
NCT02742597 2023-03-17
PACEinMM-ON
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Phase NA Completed
NCT04344886 2022-12-07
Optimization and Individualization of Diagnostic Scintigraphy Protocol and Minimally Invasive Radio-guided Parathyroid Surgery
University Hospital Ostrava
Phase NA Completed
NCT02789800 2022-11-03
PACEinMM-QC
Université de Sherbrooke
Phase NA Completed
NCT05521594 2022-09-26
Thyroid FNAC
Qena Oncology Center
Phase NA Completed
NCT04704349 2021-11-03
LISSE1
Centre Hospitalier Régional d'Orléans
Phase NA Completed
NCT04759053 2021-02-17
Effectiveness of Core-Needle US Guided Biopsy as Primary Tool For Diagnosis of Thyroid Nodules
Kafrelsheikh University
Phase NA Completed
NCT04647006 2020-11-30
TOETVA
Başakşehir Çam & Sakura City Hospital
Phase NA Completed
NCT03430141 2020-09-22
NWHS
Northern Arizona University
Phase NA Completed
NCT04425512 2020-06-11
Delta Neutrophil Index and Neutrophil Lymphocyte Ratio in Thyroid Malignancy
Kahramanmaras Sutcu Imam University
Phase NA Completed
NCT03183752 2019-04-19
Insulin Resistance and Metformin Use on Volume of Benign Thyroid Nodules
Hospital Universitário Clementino Fraga Filho
Phase NA Completed
NCT03176485 2019-01-04
Evaluation of Pathway Modulation by Raf, MEK, & Kinase Inhibitors
University of Arizona
Phase NA Completed
NCT03106337 2017-05-16
Diagnostic Accuracy of Shear-Wave Elastography for the Preoperative Risk Stratification of Follicular Lesions of the Thyroid
Massachusetts General Hospital
Phase NA Completed
NCT00970359 2017-04-12
Reacquisition of Radioactive Iodine (RAI) Uptake of RAI-Refractory Metastatic Thyroid Cancers by Pretreatment With the Selective MEK Inhibitor AZD6244
Memorial Sloan Kettering Cancer Center
Phase NA Completed